Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Neuro-Oncology
-
-
Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
-
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
-
Honoring Leadership and Celebrating New Horizons
The Alliance for Clinical Trials in Oncology thrives on the dedication, vision, and expertise of its leadership team. We express our deep gratitude to the outgoing committee chairs whose years of tireless service have fundamentally shaped our research portfolio, advanced clinical trials, and mentored the next generation of investigators while profoundly impacting the lives of…
-
Newly Activated Alliance Trials
E-News – June 2026Alliance Research Update Recently Activated Alliance Trials The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials…
-
Recently Activated Alliance Clinical Trials
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new drug combinations for rare and aggressive cancers to evaluating digital health tools that improve access to genetic services, these trials aim to improve outcomes, reduce…
-
Alliance Marks Adolescent and Young Adult Cancer Awareness Week
Each year, about 85,000 adolescents and young adults (AYA) between the ages of 15 and 39 are diagnosed with cancer in the United States. According to the National Cancer Institute, this represents about 4% of all new cancer diagnoses. Depending on age and specific diagnosis, many AYA people with cancer may be treated at either…
-
New Alliance Clinical Trial Aims to Improve Outcomes in Brain Tumors
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. Supported in part by a grant from the National Cancer Institute, the study (Alliance A072301) will…
-
February News Mentions
At the Alliance for Clinical Trials in Oncology (Alliance), we share stories highlighting the progress and impact of cancer research. By shining a light on new clinical trials, scientific discoveries, and the achievements of our investigators, we showcase the progress being made against cancer and the people driving it forward. These stories raise awareness of…
-
Alliance in the News – January 2026
February 9, 2026 – At the Alliance, we share stories highlighting the progress and impact of cancer research. By shining a light on new clinical trials, scientific discoveries, and the achievements of our investigators, we showcase the progress being made against cancer and the people driving it forward. These stories raise awareness of the essential role…
Categories
Alliance Committee
Browse by Year